About BRCF

Harvard Medical School (HMS) is now accepting applications for the Bertarelli Rare Cancers Fund (the “Fund”), available through a generous gift to HMS from the Bertarelli Foundation.

 

The Fund’s purpose is to support research projects that optimally advance our capacity to prevent, treat, and cure cancer with a focus on rarely occurring cancers.

 

Research will focus on the identification of underlying core pathways that are critical for tumor proliferation and survival. This includes investigations of genetic and epigenetic alterations that drive these phenotypes as well as tumor dependencies that will lead to identification of therapeutic strategies. Preference will be given to research associated with clear cell odontogenic carcinoma or other closely related rare cancers.

BRCF Request for Proposals

Key Dates

 

February 11, 2020

Request for Letters of Intent 

 

DEADLINE EXTENDED: March 18, 2020 (5:00 p.m. EDT)

Letters of Intent Due

 

June 25, 2020

Full Proposals Invited

 

September 15, 2020

Full Proposals Due

 

October 2020

Funding Decisions Announced

 

October/November 2020 

Anticipated Funding Start